Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Euphoric experience with different anesthetic regimens in painless gastroenteroscopy
ChiCTR2400083813Phase 4Not yet recruiting
- Sponsor
- Shenzhen University General Hospital
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and sufentanil (3 arms), sponsored by Shenzhen University General Hospital. Primary endpoints: Morphine-Benzedrine Group score and Modified Brice questionnaire. Planned start May 2024; status: not yet recruiting.
02
Drugs
remimazolampropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2400083813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083813.